47
Views
5
CrossRef citations to date
0
Altmetric
Brief Communication

The presence of blaKPC-mediated resistance in Enterobacteriaceae in Cairo University hospitals in Egypt and its correlation with in vitro carbapenem susceptibility

, , &

References

  • Hoenigl M, Valentin T, Zarfel G, Wuerstl B, Leitner E, Salzer HJF, et al.. Nosocomial Outbreak of Klebsiella pneumoniae Carbapenemas-producing Klebsiella oxytoca in Austria. Antimicrob Agents Chemother. 2010;56(4):2158–61.
  • Chu YW, Tung VWN, Cheung TKM, Chu M, Cheng N, Lai C, et al.. Carbapenemases in enterobacteria, Hong Kong, China. Emerg Infect Dis. 2009;17:130–2.
  • Cuzon G, Naas T, Truong H, Villegas M, Wisell KT, Carmeli Y, et al.. Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerg Infect Dis. 2010;16:1349–56.
  • Chen LF, Anderson DJ, Paterson DL. Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance. Infect Drug Resist. 2012;5:133–41.
  • Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al.. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4):1151–61.
  • Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M, et al.. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect. 2010;16:112–22.
  • Clinical and Laboratory Standards Institute 2010: Performance standards for antimicrobial susceptibility testing; 19th informational supplement. Document M100- S29. Wayne, PA.
  • Benenson S, Temper V, Cohen MJ, Schwartz C, Hidalgo-Grass C, Block C. Imipenem Disc for Detection of KPC Carbapenemase-Producing Enterobacteriaceae in Clinical Practice. J Clin Microbiol. 2011;49(4):1617–20.
  • Cole JM, Schuetz AN, Hill CE, Nolte FS. Development and evaluation of real-time PCR assay for detection of Klebsiella pneumoniae carbapenemase genes. J Clin Microbiol. 2009;44(2):322– 6.
  • Woodford N, Tierno PM, Young K, Tysall L, Palepou MI, Ward E, et al.. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother. 2004;48:4793–9.
  • Zagorianou A, Sianou E, Iosifidis E, Dimou V, Protonotariou E, Miyakis S, et al.. Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004–2010. Euro Surveill. 2012;17(7):pii:20088.
  • Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase–producing K. pneumoniae. Infect Control Hosp Epidemiol. 2009;30(12):1180–5.
  • Qureshi ZA, Paterson DL, Potoski BA, Kilayko MC, Sandovsky G, Sordillo E, et al.. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother. 2012;56(4):2108–13.
  • Bean DC, Krahe D, Wareham DW. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005–2006. Ann Clin Microbiol Antimicrob. 2008;7:13.
  • Clinical and Laboratory Standards Institute 2011: Performance standards for antimicrobial susceptibility testing; 19th informational supplement. Document M100-S21. Wayne, PA.
  • Landman D, Salamera J, Singh M, Quale J. Accuracy of carbapenem nonsusceptibility for identification of KPC-possessing Enterobacteriaceae by use of the revised CLSI breakpoints. J Clin Microbiol. 2011;49(11):3931–3.
  • Perez F, Endimiani A, Ray AJ, Decker BK, Wallace CJ, Hujer KM, et al.. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. J Antimicrob Chemother. 2010;65:1807–18.
  • Weisenberg SA, Morgan DJ, Espinal-Witter R, Larone DH. Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem. Diagn Microbiol Infect Dis. 2009;64:233–5.
  • Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli Hospital. Antimicrob. Agents Chemother. 2007;51(8):3026–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.